Is MC a Buy? What to Consider in 2026
Short answer
The bull case for Moelis & Company (MC) rests on M&A recovery and large-cap momentum: Moelis reported strength in large-cap M&A and a double-digit increase in sponsor-related M&A revenue in early 2026. Revenue (TTM) is ~$1.55B. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: Advisory revenue is highly cyclical and tied to the pace of deal closings, so a slowdown in M&A or capital markets can compress results quickly. Whether MC is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
Moelis & Company is a global independent investment bank founded in 2007 by Ken Moelis. It advises corporations, governments, and financial sponsors on mergers and acquisitions, restructurings and liability management, private capital raising, and other strategic matters. Unlike bulge-bracket banks, Moelis takes no principal trading or lending risk, so essentially all of its revenue comes from advisory fees earned when transactions close. The firm competes at the large-cap end of the market against other elite independents while also running a well-regarded restructuring practice that tends to stay busy when deal-making cools. The investment picture is cyclical and people-driven. Revenue swings with the pace of M&A and restructuring activity, and results can be lumpy quarter to quarter because fees are tied to closings. Moelis returns a large share of earnings to shareholders through a dividend and has been investing in senior banker hires to expand coverage. For 2026, management points to a near record backlog of announced transactions and a constructive M&A outlook, balanced against risks from geopolitical uncertainty and disruption in private credit markets that can slow closings.
What's the case for buying MC?
1. M&A recovery and large-cap momentum
Moelis reported strength in large-cap M&A and a double-digit increase in sponsor-related M&A revenue in early 2026. Management describes a near all-time-high pipeline and points to corporates seeking scale amid technological disruption as a structural tailwind for advisory demand.
2. Restructuring and liability management
The firm has a deep restructuring and liability-management practice that generates fees when companies face distress, providing a partial counterweight when M&A slows. Continued demand for liquidity solutions and capital-structure work can smooth the cyclical swings in transaction advisory.
3. Private capital advisory expansion
Private capital advisory has become a growing contributor, helping sponsors raise funds and secure liquidity. Management flags a robust backlog here as private markets keep expanding and general partners seek continuation and secondary solutions.
4. Senior banker hiring and capital return
Moelis has been adding managing directors to widen sector and geographic coverage, which raises near-term compensation costs but builds future revenue capacity. The firm returns substantial cash to shareholders, declaring a regular quarterly dividend of $0.65 per share alongside buybacks.
What are the risks to MC?
Advisory revenue is highly cyclical and tied to the pace of deal closings, so a slowdown in M&A or capital markets can compress results quickly. Compensation is the largest expense and rising banker pay can squeeze margins even when revenue grows. Geopolitical uncertainty and disruption in private credit markets can delay transactions, and the business depends heavily on retaining a relatively small group of senior rainmakers. Early 2026 results showed record quarterly revenue but adjusted earnings per share came in below analyst expectations, underscoring the sensitivity to costs and timing.
How is MC valued? (as of JULY 2026)
Snapshot for MC as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$1.55B
- Q1 2026 revenue: ~$320M (+4% YoY)
- Q1 2026 adjusted EPS: ~$0.50
- Market cap: ~$5.7B
- P/E (trailing): ~26x
- Dividend yield: ~3.6% ($0.65/quarter)
Moelis trades around $70 per share, within a 52-week range of roughly $51 to $78. Full-year 2025 adjusted revenue rose about 28% to $1.54 billion with adjusted EPS near $2.99, and the trailing multiple reflects a recovering deal cycle. The valuation embeds expectations for continued M&A and restructuring activity, so results can move sharply with the deal environment.
How do you decide if MC is a buy?
Rather than asking whether MC is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold MC indirectly through an index or sector ETF before adding more.
For the full picture, see the MC stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about MC against your real portfolio and see your actual exposure before deciding.
The bottom line on MC
The bottom line: Moelis & Company's story right now is M&A recovery and large-cap momentum, with revenue (ttm) at ~$1.55B. If you believe that narrative continues, the call is about sizing MC sensibly and checking overlap with what you own; if you doubt it (the risk: advisory revenue is highly cyclical and tied to the pace of deal closings, so a slowdown in M&A or capital markets can compress results quickly.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
Build a basket around MC with Walnut
Use Moelis & Company as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is MC a good stock to buy right now?
+
The case for Moelis & Company right now is M&A recovery and large-cap momentum, with revenue (ttm) at ~$1.55B. If you believe that thesis holds, MC is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is advisory revenue is highly cyclical and tied to the pace of deal closings, so a slowdown in M&A or capital markets can compress results quickly. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does Moelis & Company do?
+
Moelis & Company is a global independent investment bank founded in 2007 by Ken Moelis.
What are the main risks of MC?
+
Advisory revenue is highly cyclical and tied to the pace of deal closings, so a slowdown in M&A or capital markets can compress results quickly. Compensation is the largest expense and rising banker pay can squeeze margins even when revenue grows. Geopolitical uncertainty and disruption in private credit markets can delay transactions, and the business depends heavily on retaining a relatively small group of senior rainmakers. Early 2026 results showed record quarterly revenue but adjusted earnings per share came in below analyst expectations, underscoring the sensitivity to costs and timing.
What does the ticker MC stand for?
+
MC is the NYSE ticker for Moelis & Company, a global independent investment bank headquartered in New York. It should not be confused with unrelated foreign-listed companies that use similar symbols.
What does Moelis & Company actually do?
+
Moelis advises clients on mergers and acquisitions, restructurings and liability management, private capital raising, and other strategic matters. It earns fees for advice and does not take trading or lending risk on its own balance sheet.
How does Moelis make money?
+
Almost all of Moelis's revenue comes from advisory fees paid when transactions close or milestones are met. Because fees are event-driven, revenue can be lumpy from quarter to quarter and is sensitive to the overall deal environment.
Is Moelis stock cyclical?
+
Yes. Advisory revenue rises and falls with the M&A and capital-markets cycle. The restructuring practice tends to stay busier during downturns, which partially offsets weaker M&A, but overall results remain cyclical.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell MC; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.